Related Experiment Videos
Transformation assays for HPV oncoproteins
Paola Massimi1, Lawrence Banks
1International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Methods in Molecular Medicine
|December 15, 2005
Summary
Human papillomavirus (HPV) oncoproteins E6 and E7 are key drivers of cervical cancer development. This research details methods for assessing the transforming activities of these HPV oncoproteins.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human papillomavirus (HPV) types linked to cervical cancer encode potent oncoproteins.
- HPV types causing benign lesions lack these oncoproteins.
- HPV-16 E6 and E7 oncoproteins transform rodent cells and cooperate with oncogenes.
Purpose of the Study:
- To describe methods for assessing the transforming activities of HPV oncoproteins.
- To understand the role of HPV oncoproteins in cellular transformation.
Main Methods:
- Cell transformation assays using established rodent cells.
- Co-transformation assays with primary rodent cells and activated oncogenes.
- Assessment of HPV oncoprotein transforming potential.
Main Results:
- HPV-16 E6 and E7 demonstrate potent transforming activity in established rodent cells.
- E6 and E7 cooperate with other oncogenes in primary rodent cell transformation.
- HPV E5 oncoprotein exhibits weaker transforming activity in established rodent cells.
Conclusions:
- The transforming activities of HPV oncoproteins are crucial for cancer development.
- Established methods allow for the assessment of HPV oncoprotein oncogenic potential.
- Understanding these mechanisms is vital for HPV research and therapeutic strategies.